BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 10619269)

  • 1. Alendronate-associated esophageal injury: pathologic and endoscopic features.
    Abraham SC; Cruz-Correa M; Lee LA; Yardley JH; Wu TT
    Mod Pathol; 1999 Dec; 12(12):1152-7. PubMed ID: 10619269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ulcerative esophagitis associated with the use of alendronate sodium: histopathological and endoscopic features].
    Fernandes PA; Pires MS; Gouvêa AP
    Arq Gastroenterol; 2002; 39(3):173-6. PubMed ID: 12778309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].
    Tóth E; Fork FT; Lindelöw K; Lindström E; Verbaan H; Veress B
    Lakartidningen; 1998 Aug; 95(35):3676-80. PubMed ID: 9748782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alendronate-induced esophagitis. A report of 2 cases].
    Girelli CM; Reguzzoni G; Rocca F
    Recenti Prog Med; 1997 May; 88(5):223-5. PubMed ID: 9244956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.
    Terashima T; Hiramatsu K; Shimatani A; Matsuda M; Ogino H; Satomura Y; Noda Y
    Endoscopy; 2006; 38 Suppl 2():E37. PubMed ID: 17366400
    [No Abstract]   [Full Text] [Related]  

  • 6. Pill esophagitis.
    Vãlean S; Petrescu M; Cãtinean A; Chira R; Mircea PA
    Rom J Gastroenterol; 2005 Jun; 14(2):159-63. PubMed ID: 15990936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Esophagitis associated with use of alendronate in 5 postmenopausic patients].
    Luciani J; Pigatto V; Naves A; Fay M; Silvestre Begnis M; Piola JC; Prada DB; Pedrana R
    Acta Gastroenterol Latinoam; 2001 May; 31(2):59-63. PubMed ID: 11471319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases.
    Singh SP; Odze RD
    Am J Surg Pathol; 1998 Jan; 22(1):93-9. PubMed ID: 9422321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal stricture associated with alendronate therapy.
    Levine J; Nelson D
    Am J Med; 1997 May; 102(5):489-91. PubMed ID: 9217649
    [No Abstract]   [Full Text] [Related]  

  • 10. [Esophageal lesions associated with diphosphonates].
    Larsen KO; Stray N; Engh V; Sandnes D
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2397-9. PubMed ID: 11475224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new probable increasing cause of esophageal ulceration: alendronate.
    Colina RE; Smith M; Kikendall JW; Wong RK
    Am J Gastroenterol; 1997 Apr; 92(4):704-6. PubMed ID: 9128331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophagitis and alendronate.
    Liberman UI; Hirsch LJ
    N Engl J Med; 1996 Oct; 335(14):1069-70. PubMed ID: 8801453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Esophagitis due to alendronate. Report of two cases].
    Tronci S
    Minerva Gastroenterol Dietol; 1998 Sep; 44(3):159-62. PubMed ID: 16495898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophagitis dissecans superficialis ("sloughing esophagitis"): a clinicopathologic study of 12 cases.
    Carmack SW; Vemulapalli R; Spechler SJ; Genta RM
    Am J Surg Pathol; 2009 Dec; 33(12):1789-94. PubMed ID: 19809273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doxycycline esophagitis and esophageal ulcer].
    Kolarski V; Petrova-Shopova K; Nikolov S; Vasileva E; Petrova D
    Vutr Boles; 1988; 27(1):63-7. PubMed ID: 3414086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of human immunodeficiency virus-associated esophageal disease.
    Bonacini M; Young T; Laine L
    Am J Gastroenterol; 1993 Apr; 88(4):549-51. PubMed ID: 8204115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pill-induced esophageal injury: endoscopic features and clinical outcomes.
    Abid S; Mumtaz K; Jafri W; Hamid S; Abbas Z; Shah HA; Khan AH
    Endoscopy; 2005 Aug; 37(8):740-4. PubMed ID: 16032493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Esophageal ulcers induced by doxycycline. Evaluation of 4 cases].
    Ramírez Ramos A; Valladares G; Barreda Costa C
    Acta Gastroenterol Latinoam; 1981; 11(2):309-13. PubMed ID: 7336852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophagitis associated with the use of alendronate.
    de Groen PC; Lubbe DF; Hirsch LJ; Daifotis A; Stephenson W; Freedholm D; Pryor-Tillotson S; Seleznick MJ; Pinkas H; Wang KK
    N Engl J Med; 1996 Oct; 335(14):1016-21. PubMed ID: 8793925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.